eHuman γ-Herpesvirus infection, Tumorigenesis, and immune Control in Mice with Reconstituted Human immune System Components

被引:6
|
作者
Munz, Christian [1 ]
机构
[1] Univ Zurich, Inst Expt Immunol, Viral Immunobiol, Zurich, Switzerland
来源
FRONTIERS IN IMMUNOLOGY | 2018年 / 9卷
基金
瑞士国家科学基金会;
关键词
Epstein-Barr virus; Kaposi sarcoma-associated herpesvirus; natural killer cells; T cells; primary effusion lymphoma; lymphoproliferative disease; EPSTEIN-BARR-VIRUS; NATURAL-KILLER-CELLS; KAPOSIS-SARCOMA; KSHV INFECTION; MOUSE MODEL; IN-VIVO; EBV; EXPRESSION; RESPONSES; LYMPHOMA;
D O I
10.3389/fimmu.2018.00238
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The human gamma-herpesviruses Epstein-Barr virus (EBV or HHV4) and Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) are each associated with around 2% of all tumors in humans worldwide. However, investigations into their infection, oncogenesis, and immune responses that protect from the associated tumors have been hampered by the exclusive tropism of these pathogens for humans. Mice with reconstituted human immune system components (HIS mice) provide the unique opportunity to study persistent infection, virus associated lymphoma formation, and cell-mediated immune control of EBV and KSHV. Moreover, since these pathogens are unique stimuli for cytotoxic human lymphocyte responses, they also allow us to characterize long-lasting cell-mediated immune control and the requirements for its initiation, which would also be desirable to achieve during antitumor vaccination in general. Thus, human gamma-herpesvirus infection of HIS mice provides unique insights into the biology of these important human pathogens and human cell-mediated immune responses that are considered to be the main protective entity against tumors.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Immune System Has Unexpected Role in Tumorigenesis
    Genetic Engineering and Biotechnology News, 2021, 41 (11):
  • [42] THE HUMAN IMMUNE-RESPONSE TO RECONSTITUTED BOVINE COLLAGEN
    ELLINGSWORTH, LR
    DELUSTRO, F
    BRENNAN, JE
    SAWAMURA, S
    MCPHERSON, J
    JOURNAL OF IMMUNOLOGY, 1986, 136 (03): : 877 - 882
  • [43] THE INFLUENCE OF SURGICAL OPERATIONS ON COMPONENTS OF THE HUMAN IMMUNE-SYSTEM
    LENNARD, TWJ
    SHENTON, BK
    BORZOTTA, A
    WHITE, M
    GERRIE, LM
    PROUD, G
    TAYLOR, RMR
    BRITISH JOURNAL OF SURGERY, 1985, 72 (10) : 771 - 776
  • [44] Strongyloides ratti infection in mice: immune response and immune modulation
    Breloer, Minka
    Linnemann, Lara
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2024, 379 (1894)
  • [45] Immune control of HIV infection
    Lévy, Y
    M S-MEDECINE SCIENCES, 2001, 17 (01): : 133 - 134
  • [46] Lactobacillus paracasei feeding improves immune control of influenza infection in mice
    Belkacem, Nouria
    Serafini, Nicolas
    Wheeler, Richard
    Derrien, Muriel
    Boucinha, Lilia
    Couesnon, Aurelie
    Cerf-Bensussan, Nadine
    Boneca, Ivo Gomperts
    Di Santo, James P.
    Taha, Muhamed-Kkeir
    Bourdet-Sicard, Raphaelle
    PLOS ONE, 2017, 12 (09):
  • [47] Regulation of ovarian function by immune system components: The tissue control system (TCS)
    Bukovsky, A
    Caudle, MR
    Keenan, JA
    MICROSCOPY OF REPRODUCTION AND DEVELOPMENT : A DYNAMIC APPROACH: A DYNAMIC APPROACH, 1997, : 79 - 89
  • [48] Early establishment of γ-herpesvirus latency:: Implications for immune control
    Flaño, E
    Jia, QM
    Moore, J
    Woodland, DL
    Sun, R
    Blackman, MA
    JOURNAL OF IMMUNOLOGY, 2005, 174 (08): : 4972 - 4978
  • [49] Isotype immune response of IgG antibodies at the persistence and reactivation stages of human herpesvirus 6 infection
    Pavan, J. V.
    Bustos, D.
    Ferreyra, L.
    Biganzoli, P.
    Carricart, S. E.
    Nates, S. V.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 37 : S106 - S106
  • [50] The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection
    Jin, Ximing
    Wang, Wenjia
    Zhao, Xinwei
    Jiang, Wenhua
    Shao, Qingqing
    Chen, Zhuo
    Huang, Cong
    FRONTIERS IN IMMUNOLOGY, 2023, 14